Not for the Macular Degeneration Late Stage Application that is still under study. Those are the Partnerships we are all waiting to hear about. Would be new and novel application for late stage Macular Degeneration that no other bio has shown yet. Was reversing the damage at this stage, all in the Conference call. If it is reproducible consistently-Watch out.
News 
Market Data 
Discover 
AI
